PDB Short entry for 2IIL
HEADER                                            28-SEP-06   2IIL              
TITLE     NEUROPEPTIDE Y1 RECEPTOR                                              
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: PROTEINS:  NEUROPEPTIDE Y1 RECEPTOR                        
COMPND   3  TRANSMEMBRANE PROTEIN  HOMO SAPIENS;                                
COMPND   4 CHAIN: NULL                                                          
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 OTHER_DETAILS: BRAIN                                                 
KEYWDS    HELIX, NEUROPEPTIDE Y1 RECEPTOR, TRANSMEMBRANE PROTEIN,               
EXPDTA    THEORETICAL MODEL                                                     
AUTHOR    PULIPAKA KALYAN CHAITANYA,ANNABHIMOJU RAMAKRISHNA,                    
AUTHOR   2 VURUPUTURI UMA                                                       
REVDAT   1   10-OCT-06 2IIL    0                                                
REMARK   1                                                                      
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : SCHRODINGER SUITE 2005                               
REMARK   3   AUTHORS     : SCHRODINGER                                          
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: REFINEMENT COMPONENT USES IMPACT TO       
REMARK   3  RUN A SERIES OF RESTRAINED, PARTIAL MINIMIZATIONS ON THE            
REMARK   3  COMBINED, HYDROGENATED STRUCTURE. MINIMIZATIONS CONTINUE UNTIL      
REMARK   3  THE AVERAGE RMS DEVIATION OF THE NON-HYDROGEN ATOMS REACHES         
REMARK   3  THE SPECIFIED LIMIT (0.3 BY DEFAULT).                               
REMARK   4                                                                      
REMARK   4 2IIL COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998                       
REMARK 100                                                                      
REMARK 100 THIS ENTRY WAS DEPOSITED AT RCSB ON 28-SEP-2006.                     
REMARK 100 THE RCSB ID CODE IS RCSB039615.                                      
REMARK 220                                                                      
REMARK 220 EXPERIMENTAL DETAILS                                                 
REMARK 220  EXPERIMENT TYPE                : THEORETICAL MODELLING              
REMARK 220                                                                      
REMARK 220 REMARK: THIS THEORETICAL MODEL ENTRY WAS NOT ANNOTATED AND NOT       
REMARK 220         VALIDATED BY THE WWPDB STAFF AND THEREFORE MAY NOT           
REMARK 220         CONFORM TO THE PDB FORMAT.                                   
REMARK 225                                                                      
REMARK 225 THEORETICAL MODEL                                                    
REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE.           
REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND                
REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE                   
REMARK 225 RECORDS ARE MEANINGLESS.                                             
REMARK 888                                                                      
REMARK 888 WRITTEN BY MAESTRO (A PRODUCT OF SCHRODINGER, LLC)                   
SEQRES   1    384  MET ASN SER THR LEU PHE SER GLN VAL GLU ASN HIS SER          
SEQRES   2    384  VAL HIS SER ASN PHE SER GLU LYS ASN ALA GLN LEU LEU          
SEQRES   3    384  ALA PHE GLU ASN ASP ASP CYS HIS LEU PRO LEU ALA MET          
SEQRES   4    384  ILE PHE THR LEU ALA LEU ALA TYR GLY ALA VAL ILE ILE          
SEQRES   5    384  LEU GLY VAL SER GLY ASN LEU ALA LEU ILE ILE ILE ILE          
SEQRES   6    384  LEU LYS GLN LYS GLU MET ARG ASN VAL THR ASN ILE LEU          
SEQRES   7    384  ILE VAL ASN LEU SER PHE SER ASP LEU LEU VAL ALA ILE          
SEQRES   8    384  MET CYS LEU PRO PHE THR PHE VAL TYR THR LEU MET ASP          
SEQRES   9    384  HIS TRP VAL PHE GLY GLU ALA MET CYS LYS LEU ASN PRO          
SEQRES  10    384  PHE VAL GLN CYS VAL SER ILE THR VAL SER ILE PHE SER          
SEQRES  11    384  LEU VAL LEU ILE ALA VAL GLU ARG HIS GLN LEU ILE ILE          
SEQRES  12    384  ASN PRO ARG GLY TRP ARG PRO ASN ASN ARG HIS ALA TYR          
SEQRES  13    384  VAL GLY ILE ALA VAL ILE TRP VAL LEU ALA VAL ALA SER          
SEQRES  14    384  SER LEU PRO PHE LEU ILE TYR GLN VAL MET THR ASP GLU          
SEQRES  15    384  PRO PHE GLN ASN VAL THR LEU ASP ALA TYR LYS ASP LYS          
SEQRES  16    384  TYR VAL CYS PHE ASP GLN PHE PRO SER ASP SER HIS ARG          
SEQRES  17    384  LEU SER TYR THR THR LEU LEU LEU VAL LEU GLN TYR PHE          
SEQRES  18    384  GLY PRO LEU CYS PHE ILE PHE ILE CYS TYR PHE LYS ILE          
SEQRES  19    384  TYR ILE ARG LEU LYS ARG ARG ASN ASN MET MET ASP LYS          
SEQRES  20    384  MET ARG ASP ASN LYS TYR ARG SER SER GLU THR LYS ARG          
SEQRES  21    384  ILE ASN ILE MET LEU LEU SER ILE VAL VAL ALA PHE ALA          
SEQRES  22    384  VAL CYS TRP LEU PRO LEU THR ILE PHE ASN THR VAL PHE          
SEQRES  23    384  ASP TRP ASN HIS GLN ILE ILE ALA THR CYS ASN HIS ASN          
SEQRES  24    384  LEU LEU PHE LEU LEU CYS HIS LEU THR ALA MET ILE SER          
SEQRES  25    384  THR CYS VAL ASN PRO ILE PHE TYR GLY PHE LEU ASN LYS          
SEQRES  26    384  ASN PHE GLN ARG ASP LEU GLN PHE PHE PHE ASN PHE CYS          
SEQRES  27    384  ASP PHE ARG SER ARG ASP ASP ASP TYR GLU THR ILE ALA          
SEQRES  28    384  MET SER THR MET HIS THR ASP VAL SER LYS THR SER LEU          
SEQRES  29    384  LYS GLN ALA SER PRO VAL ALA PHE LYS LYS ILE ASN ASN          
SEQRES  30    384  ASN ASP ASP ASN GLU LYS ILE                                  
HELIX    1   1 LEU     37  GLY     48  1                                  12    
HELIX    2   2 ALA     49  GLN     68  1                                  20    
HELIX    3   3 ASN     73  CYS     93  1                                  21    
HELIX    4   4 CYS     93  ASP    104  1                                  12    
HELIX    5   5 GLY    109  ASN    144  1                                  36    
HELIX    6   6 ASN    151  LEU    171  1                                  21    
HELIX    7   7 PRO    172  TYR    176  5                                   5    
HELIX    8   8 HIS    207  GLN    219  1                                  13    
HELIX    9   9 TYR    220  ARG    237  1                                  18    
HELIX   10  10 LYS    252  ILE    281  1                                  30    
HELIX   11  11 THR    284  HIS    290  1                                   7    
HELIX   12  12 HIS    298  MET    310  1                                  13    
HELIX   13  13 ILE    311  ASN    324  1                                  14    
HELIX   14  14 ARG    329  PHE    337  1                                   9    
SHEET    1   A 2 MET   179  ASP   181  0                                        
SHEET    2   A 2 VAL   187  LEU   189 -1  O  THR   188   N  THR   180           
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000